Compare BLLN & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | AVNT |
|---|---|---|
| Founded | 2016 | 1927 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.4B |
| IPO Year | N/A | 2000 |
| Metric | BLLN | AVNT |
|---|---|---|
| Price | $96.06 | $33.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $126.71 | $41.50 |
| AVG Volume (30 Days) | ★ 771.8K | 688.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.04% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $3,835,500,000.00 |
| Revenue This Year | $46.29 | $4.90 |
| Revenue Next Year | $30.14 | $3.48 |
| P/E Ratio | ★ N/A | $55.67 |
| Revenue Growth | N/A | ★ 1.71 |
| 52 Week Low | $61.96 | $27.48 |
| 52 Week High | $138.70 | $44.85 |
| Indicator | BLLN | AVNT |
|---|---|---|
| Relative Strength Index (RSI) | 55.60 | 41.87 |
| Support Level | $79.07 | $31.89 |
| Resistance Level | $97.36 | $37.74 |
| Average True Range (ATR) | 7.92 | 1.04 |
| MACD | 0.95 | -0.02 |
| Stochastic Oscillator | 58.11 | 36.94 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.